4//SEC Filing
Ambrose Kristen 4
Accession 0000875320-25-000079
CIK 0000875320other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:21 PM ET
Size
6.1 KB
Accession
0000875320-25-000079
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2025-02-14$463.46/sh−564$261,391→ 11,469 total - Sale
Common Stock
2025-02-18$455.06/sh−671$305,345→ 10,798 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001856587
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:21 PM ET
- Size
- 6.1 KB